Kristy A. Carpenter, PhD

Kristy A. Carpenter, PhD

she/her

Computational biologist passionate about accelerating drug discovery with computation and big data. PhD in Biomedical Informatics.

Publications

Selected peer-reviewed papers and preprints in reverse chronological order. For a complete list of publications, please see my CV or my Google Scholar profile.

All Protein Structure Social Media & Opioids Drug Discovery
Representative figure for PIGLET paper
Drug-Target Interaction Prediction with PIGLET
K.A. Carpenter, R.B. Altman — bioRxiv (2026)
Drug Discovery
Representative figure for disambiguation paper
Large language models can disambiguate opioid slang on social media
K.A. Carpenter, I.A. Samori, M.V. Kiang, K. Humphreys, A. Lembke, J.C. Eichstaedt, R.B. Altman — arXiv (2026)
Social Media & Opioids
Representative figure for HOTPocket paper
The Human Omnibus of Targetable Pockets
K.A. Carpenter, R.B. Altman — J. Chem. Inf. (2025)
Protein Structure Drug Discovery
Representative figure for social media platform comparison paper
Which social media platforms facilitate monitoring the opioid crisis?
K.A. Carpenter, A.T. Nguyen, D.A. Smith, I.A. Samori, K. Humphreys, A. Lembke, M.V. Kiang, J.C. Eichstaedt, R.B. Altman — PLOS Digit. Health (2025)
Social Media & Opioids
Representative figure for pocket databases review
Databases of ligand-binding pockets and protein-ligand interactions
K.A. Carpenter, R.B. Altman — Comput. Struct. Biotechnol. J. (2024)
Protein Structure Drug Discovery
Representative figure for paper using GPT-3 to generate drugs of abuse lexicon
Using GPT-3 to Build a Lexicon of Drugs of Abuse Synonyms for Social Media Pharmacovigilance
K.A. Carpenter, R.B. Altman — Biomolecules (2023)
Social Media & Opioids
Representative figure for study on training data composition for protein structure ML
Training data composition affects performance of protein structure analysis algorithms
A. Derry*, K.A. Carpenter*, R.B. Altman — Pac. Symp. Biocomput. (2022)
Protein Structure
Representative figure for review on ML for virtual screening
Machine learning-based virtual screening and its applications to Alzheimer's drug discovery: a Review
K.A. Carpenter, X. Huang — Curr. Pharm. Des. (2018)
Drug Discovery